Minerva Neurosciences | NERV - Zobowiązania Handlowe





Zobowiązania Handlowe Zmiana Data
Acadia Pharmaceuticals USD 16.33M 28.24M 2026-09
Adma Biologics USD 35.66M 3.94M 2026-09
ALKERMES USD 107.69M 35.17M 2026-09
Alterity Therapeutics Limited AUD 1.07M 203.72K 2025-12
AstraZeneca USD 23.57B 679M 2026-09
BioCryst Pharmaceuticals USD 14.58M 3.12M 2026-09
Bristol-Myers Squibb USD 4.63B 470M 2026-09
Cipla INR 32.66B 361.1M 2026-09
Clal Biotechnology ILS 21.05M 1.62M 2021-12
Compugen USD 2.15M 371K 2026-06
CSL USD 3.17B 290M 2025-12
Eli Lilly USD 5.79B 319M 2026-09
GlaxoSmithKline GBP 15.63B 1.29B 2026-09
Grifols EUR 987.75M 47.87M 2025-12
Halozyme Therapeutics USD 33.55M 9.94M 2026-09
Ionis Pharmaceuticals USD 47.7M 21.67M 2026-06
J&J USD 9.32B 94M 2026-09
Merck USD 5.03B 1.2B 2026-09
Minerva Neurosciences USD 640K 305K 2025-12
Neurocrine Biosciences USD 754.1M 612.1M 2026-09
Novartis USD 4.24B 15M 2026-09
Novavax USD 24.94M 2.01M 2026-09
Pfizer USD 4.07B 511M 2026-09
Roche Holding CHF 5.54B 237M 2026-06
Sanofi EUR 24.55B 957M 2026-09
Takeda JPY 486.2B 39.41B 2026-09
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12